DongKoo Bio & Pharma Co., Ltd. (KOSDAQ:006620)
South Korea
· Delayed Price · Currency is KRW 5,760.00
-80.00 (-1.37%)
At close: Dec 5, 2025
DongKoo Bio & Pharma Revenue
DongKoo Bio & Pharma had revenue of 62.02B KRW in the quarter ending September 30, 2025, a decrease of -6.29%. This brings the company's revenue in the last twelve months to 238.39B, down -6.04% year-over-year. In the year 2024, DongKoo Bio & Pharma had annual revenue of 249.27B with 15.57% growth.
Revenue (ttm)
238.39B
Revenue Growth
-6.04%
P/S Ratio
0.65
Revenue / Employee
590.07M
Employees
404
Market Cap
155.76B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 315.56T |
| SK hynix | 84.09T |
| LG Energy Solution | 23.98T |
| Samsung Biologics | 5,504.84B |
| Hyundai Motor Company | 186.04T |
| Doosan Enerbility | 16.79T |
| KB Financial Group | 14.89T |
| HD Hyundai Heavy Industries | 16.39T |